Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Dermatology Specialties Limited Partnership
- Target Recruit Count
- 107
- Registration Number
- NCT03826628
- Locations
- ðŸ‡ðŸ‡º
University of Pécs, Pécs, Hungary
🇺🇸University of California San Diego, La Jolla, California, United States
🇪🇸Clinica Universidad de Navarra, Pamplona, Navarra, Spain
© Copyright 2024. All Rights Reserved by MedPath